Clinical Outcome

P-13.2.8 - Matrix-induced Autologous Chondrocyte Implantation of Talus Osteochondral Defect (ID 10556)

Authors
Corresponding Author
Disclosure
No Significant Commercial Relationships
Topic
Clinical Outcome
Rating
 | 

Previous ePoster
P-13.2.4 - Does dGEMRIC Provide An Advantage Over Conventional MRI In The Evaluation Of Hip Chondral Injury?: A Systematic Review (ID 10492)

Next ePosters
P-13.3.3 - Platelet-Rich Plasma Intra-Articular Knee Injections Vs Viscosupplementation: Long-Term Results Of A RCT (ID 10416)
P-13.3.4 - A 52 week Randomized, Double-Blind Phase 2 Study Of Intra-Articular, Wnt Pathway Inhibitor (SM04690) For Osteoarthritis (ID 10440)
P-13.3.7 - Threshold Values for Preoperative Patient Reported Outcome Scores to Predict Global Function following ACI (ID 10548)
P-13.3.10 - Repair of large chondral lesions with single - step chondrocyte and bone marrow cells co - transplantation. (ID 10573)
P-13.4.1 - Collagen Assessment Of The Low-Grade Cartilage Lesions Using T2 Mapping At 3 And 7 Tesla MRI: One Year Follow-Up Study (ID 10383)
P-13.4.3 - Joint space width criteria can reduce knee OA trial heterogeneity: P2 post-hoc data from Wnt pathway inhibitor, SM04690 (ID 10451)
P-13.4.7 - Comparison of Cartilage Lesions morphologic properties prepared by Standard Curette and Specialized Chondrectoms (ID 10497)
P-13.4.8 - Quality of cartilage repair after 6 years of Autologous Chondrocyte Implantation (ID 10522)
P-15.1.2. - Role Of Scaffold Mean Pore Size In Meniscus Regeneration (ID 10413)
P-15.1.6 - 3D-Printed Poly (Epsilon-Caprolactone) Scaffold Combined With ECM-Based Hydrogel For Tissue-Engineered Meniscus (ID 10444)